カナダ - 英語 - Health Canada

sandoz canada incorporated - enoxaparin sodium - solution - 30mg - enoxaparin sodium 30mg - heparins

カナダ - 英語 - Health Canada

sandoz canada incorporated - enoxaparin sodium - solution - 40mg - enoxaparin sodium 40mg - heparins

カナダ - 英語 - Health Canada

sandoz canada incorporated - enoxaparin sodium - solution - 60mg - enoxaparin sodium 60mg - heparins

カナダ - 英語 - Health Canada

sandoz canada incorporated - enoxaparin sodium - solution - 80mg - enoxaparin sodium 80mg - heparins

カナダ - 英語 - Health Canada

sandoz canada incorporated - enoxaparin sodium - solution - 100mg - enoxaparin sodium 100mg - heparins

カナダ - 英語 - Health Canada

sandoz canada incorporated - enoxaparin sodium - solution - 120mg - enoxaparin sodium 120mg - heparins

カナダ - 英語 - Health Canada

sandoz canada incorporated - enoxaparin sodium - solution - 150mg - enoxaparin sodium 150mg - heparins

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

rx pharma-pack, inc. - propofol (unii: yi7vu623sf) (propofol - unii:yi7vu623sf) - propofol 10 mg in 1 ml - diprivan is an iv general anesthetic and sedation drug that can be used as described in the table below. safety, effectiveness and dosing guidelines for diprivan have not been established for mac sedation in the pediatric population; therefore, it is not recommended for this use (see precautions, pediatric use ). diprivan is not recommended for induction of anesthesia below the age of 3 years or for maintenance of anesthesia below the age of 2 months because its safety and effectiveness have not been established in those populations. in the intensive care unit (icu), diprivan can be administered to intubated, mechanically ventilated adult patients to provide continuous sedation and control of stress responses only by persons skilled in the medical management of critically ill patients and trained in cardiovascular resuscitation and airway management. diprivan is not indicated for use in pediatric icu sedation since the safety of this regimen has not been established (see precautions, pediatric use ). dipri

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

rx pharma-pack, inc. - propofol (unii: yi7vu623sf) (propofol - unii:yi7vu623sf) - propofol 10 mg in 1 ml - diprivan is an iv general anesthetic and sedation drug that can be used as described in the table below. table 3.  indications for diprivan safety, effectiveness and dosing guidelines for diprivan have not been established for mac sedation in the pediatric population; therefore, it is not recommended for this use (see precautions, pediatric use ). diprivan is not recommended for induction of anesthesia below the age of 3 years or for maintenance of anesthesia below the age of 2 months because its safety and effectiveness have not been established in those populations. in the intensive care unit (icu), diprivan can be administered to intubated, mechanically ventilated adult patients to provide continuous sedation and control of stress responses only by persons skilled in the medical management of critically ill patients and trained in cardiovascular resuscitation and airway management. diprivan is not indicated for use in pediatric icu sedation since the safety of this regimen has not been established (see pr

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

life line home care services, inc. - ondansetron hydrochloride (unii: nmh84ozk2b) (ondansetron - unii:4af302esos) - ondansetron 8 mg - - prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin ≥ 50 mg/m2 . - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. - prevention of nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen. - prevention of postoperative nausea and/or vomiting. as with other antiemetics, routine prophylaxis is not recommended for patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. in patients where nausea and/or vomiting must be avoided postoperatively, ondansetron tablets, usp are recommended even where the incidence of postoperative nausea and/or vomiting is low. the concomitant use of apomorphine with ondansetron is contraindicated based on reports of profound hypotension and loss of consciousness when apomorphine was administ